Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Dienogest

Classification: B

Drug products: Climodien, Dienorette, Endovelle, Lafamme, Qlaira, Visanne

ATC code: G03AA16, G03AB08, G03DB08, G03FA15

Substances: dienogest

Summary

As the substance is only used by women, analyses on sex or gender differences have not been considered relevant.

Additional information

The approved indication for dienogest alone is endometriosis. The approved indication for dienogest in combination with ethinyl estradiol or estradiol is contraception [1,2].

Updated: 2016-12-23

Date of litterature search: 2016-12-20

References

Fass.se [cited 2016-12-20]. länk
Andres Mde P, Lopes LA, Baracat EC, Podgaec S. Dienogest in the treatment of endometriosis: systematic review. Arch Gynecol Obstet. 2015;292:523-9. PubMed
Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-12-19.] Socialstyrelsens statistikdatabas

Authors: Mia von Euler, Linnéa Karlsson Lind

Reviewed by: Mia von Euler

Approved by: Karin Schenck-Gustafsson